PicoSure Focus cleared by FDA for acne scar treatment

20 Aug 2014

Aesthetic manufacturer Cynosure announced that it has received FDA clearance to market PicoSure Focus for the treatment of acne scars.

Aesthetic manufacturer Cynosure announced that it has received FDA clearance to market PicoSure Focus for the treatment of acne scars.

The treatment uses laser technology that claims to revitalise and rid the skin of imperfections in just 30 minutes.  

Where other lasers use a photo-thermal action (heat), Picosure Focus’ ultra-short pulse aims to create an intense photomechanical impact, known as PressureWave. Cynosure claims that this creates shockwaves in the dermis, generating collagen and elastin and resulting in dramatic improvements, without the associated downtime.

As well as being recommended for acne scarring and revitalisation, PicoSure Focus can be used for toning, texture, wrinkles and fine lines. In 2012 it was granted FDA approval for the removal of tattoos and pigmented lesions.

Comments

Log-in to post a comment